GlassScriptPhysician profile
Julie Cho
NPI 1558592204
$1,616.29
in general payments reported to CMS, 2019-2025
13 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $78.68 · 2021: $125 · 2022: $220 · 2023: $86.30 · 2024: $733 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,031.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $550.31 | 2024 | Optilight |
| Johnson & Johnson Vision Care, INC. | $257.39 | 2020-2025 | |
| Tarsus Pharmaceuticals, INC. | $210.52 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $161.79 | 2021-2025 | Dailies Total1 |
| Allergan, INC. | $96.76 | 2019 | |
| Carl Zeiss Meditec, INC. | $81.95 | 2019-2020 | |
| Sight Sciences, INC. | $79.02 | 2025 | Omni Surgical System |
| Coopervision INC. | $72.41 | 2023 | Myday Contact Lens |
| Oasis Medical, INC. | $26.54 | 2020-2023 | Oasis Tears |
| Sun Pharmaceutical Industries INC. | $22.97 | 2022 | |
| Oyster Point Pharma, INC. | $22.18 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Dompe US, INC. | $15.05 | 2025 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.